Neurochemical responses to 6-hydroxydopamine and L-dopa therapy: implications for Parkinson's disease (Q36349458)

13 August 2017

1 reference

title

Neurochemical responses to 6-hydroxydopamine and L-dopa therapy: implications for Parkinson's disease (English)

1 reference

13 August 2017

Zigmond MJ

1

1 reference

13 August 2017

Hastings TG

series ordinal

2

1 reference

13 August 2017

Abercrombie ED

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 May 1992

1 reference

Annals of the New York Academy of Sciences

13 August 2017

1 reference

13 August 2017

648

1 reference

13 August 2017

71-86

1 reference

Effect of chemical sympathectomy on the content of acetylcholine, choline and choline acetyltransferase activity in the cat spleen and iris.

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

The Pharmacology of 6-Hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

6-hydroxy-dopamine induced degeneration of central monoamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Regional effects of 6-hydroxydopamine on catecholamine containing neurones in rat brain and spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Neuronal degeneration in rat brain induced by 6-hydroxydopamine; a histological and biochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Injection of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Effects of 6-hydroxydopamine on putative transmitter substances in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Effects of 6-hydroxydopamine on acetylcholine and GABA metabolism in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Chemical neurotoxins as denervation tools in neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Mechanisms of action of 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Compensations after lesions of central dopaminergic neurons: some clinical and basic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Effect of central catecholamine alterations on the hypothermic response to 6‐hydroxydopamine in desipramine treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

A comparison of the eating in response to hypothermic and glucoprivic challenges after nigral 6-hydroxydopamine and lateral hypothalamic electrolytic lesions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Stress-induced neurological impairments in an animal model of parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Feeding and drinking deficits after 6-hydroxydopamine administration in the rat: similarities to the lateral hypothalamic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Reinstatement of eating by dopamine agonists in aphagic dopamine denervated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

LH syndrome and brain catecholamine levels after lesions of the nigrostriatal bundle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

The effects of dopamine-depleting brain lesions on the electrophysiological activity of rat substantia nigra dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Increased midbrain dopaminergic cell activity following 2'CH3-MPTP-induced dopaminergic cell loss: an in vitro electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Sprouting of serotoninergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Neurochemical Compensation After Nigrostriatal Bundle Injury in an Animal Model of Preclinical Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Short-term effects of dopamine-depleting brain lesions on spontaneous activity of striatal neurons: relation to local dopamine concentration and behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Short-term increase and long-term reversion of striatal cell activity after degeneration of the nigrostriatal dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenger rna levels in the striatum, the entopeduncular nucleus and the lateral hypothalamus of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Altered response to apomorphine in 6-hydroxydopamine-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Dopamine release in rat striatum after administration ofl-DOPA as studied with in vivo electrochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

The effect of l-DOPA on in vivo dopamine release from nigrostriatal bundle neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Effects of L-dopa and L-tyrosine on release of free and conjugated dopamine, homovanillic acid and dihydroxyphenylacetic acid from slices of rat striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

The effects of L-dopa on in vitro dopamine release from striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Nonaminergic striatal neurons convert exogenous l-dopa to dopamine in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Irreversible binding of dopa and dopamine metabolites to protein by rat liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine and MPTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Nerve terminal damage in cerebral ischemia: protective effect of alpha-methyl-para-tyrosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

Growth of Pulmonary Alveolar Macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB24525.X

10.1111/J.1749-6632.1992.TB24525.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference